EP0349594A4 - Recombinant baculovirus occlusion bodies in vaccines and biological insecticides - Google Patents

Recombinant baculovirus occlusion bodies in vaccines and biological insecticides

Info

Publication number: EP0349594A4
Authority: EP; European Patent Office
Prior art keywords: vaccines; recombinant baculovirus; biological insecticides; occlusion bodies; baculovirus occlusion
Prior art date: 1987-03-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP19880904294

Other versions

EP0349594A1 (en

Inventor

Malcolm J. Fraser

Elliot D. Rosen

Victoria A. Ploplis

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

American Biogenetic Sciences Inc

Original Assignee

American Biogenetic Sciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-03-16

Filing date

1988-03-02

Publication date

1990-09-26

1988-02-08 Priority claimed from US07/153,736 external-priority patent/US4870023A/en

1988-03-02 Application filed by American Biogenetic Sciences Inc filed Critical American Biogenetic Sciences Inc

1990-01-10 Publication of EP0349594A1 publication Critical patent/EP0349594A1/en

1990-09-26 Publication of EP0349594A4 publication Critical patent/EP0349594A4/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Zoology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Virology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Chemistry (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

EP19880904294 1987-03-16 1988-03-02 Recombinant baculovirus occlusion bodies in vaccines and biological insecticides Withdrawn EP0349594A4 (en)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
US2649987A	1987-03-16	1987-03-16
US2649887A	1987-03-16	1987-03-16
US07/153,736 US4870023A (en)	1987-03-16	1988-02-08	Recombinant baculovirus occlusion bodies in vaccines and biological insecticides
US153736		1988-02-08
US26499		1993-03-04
US26498		2004-12-30

Publications (2)

Publication Number	Publication Date
EP0349594A1 EP0349594A1 (en)	1990-01-10
EP0349594A4 true EP0349594A4 (en)	1990-09-26

Family

ID=27362785

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP19880904294 Withdrawn EP0349594A4 (en)	1987-03-16	1988-03-02	Recombinant baculovirus occlusion bodies in vaccines and biological insecticides

Country Status (4)

Country	Link
EP (1)	EP0349594A4 (en)
JP (1)	JPH02502876A (en)
AU (1)	AU1717688A (en)
WO (1)	WO1988007082A1 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2631974B1 (en) *	1988-05-31	1992-12-11	Agronomique Inst Nat Rech	MODIFIED BACULOVIRUS, ITS PREPARATION METHOD AND ITS APPLICATION AS A GENE EXPRESSION VECTOR
US5145775A (en) *	1989-02-28	1992-09-08	Research Association For Biotechnology Of Agricultural Chemicals	Polyhedrin gene and genetic engineering thereof
NZ243851A (en) *	1991-08-05	1995-02-24	Commw Scient Ind Res Org	Recombinant viruses and their use in biological insecticides
US5762939A (en) *	1993-09-13	1998-06-09	Mg-Pmc, Llc	Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
EP2374894B1 (en) *	1993-09-13	2014-09-17	Protein Sciences Corporation	A method for producing influenza hemagglutinin multivalent vaccines
FR2761994B1 (en)	1997-04-11	1999-06-18	Centre Nat Rech Scient	PREPARATION OF MEMBRANE RECEPTORS FROM EXTRACELLULAR BACULOVIRUSES
KR100264953B1 (en) *	1998-04-03	2001-03-02	박현우	Recombinant baculovirus, process for preparing thereof and microbial insecticides containing same
WO2002036785A1 (en) *	2000-10-30	2002-05-10	Protein Crystal Co., Ltd.	Protein complexes and process for producing the same
CA2553035A1 (en)	2004-02-02	2005-08-18	Ambrx, Inc.	Modified human growth hormone polypeptides and their uses
JP2008503217A (en)	2004-06-18	2008-02-07	アンブレツクス・インコーポレイテツド	Novel antigen-binding polypeptides and their use
EP1771573A4 (en)	2004-07-21	2009-02-18	Ambrx Inc	Biosynthetic polypeptides utilizing non-naturally encoded amino acids
ATE542920T1 (en)	2004-12-22	2012-02-15	Ambrx Inc	MODIFIED HUMAN GROWTH HORMONE
CN102732588B (en)	2004-12-22	2015-01-07	Ambrx公司	Compositions of aminoacyl-trna synthetase and uses thereof
BRPI0519170A8 (en)	2004-12-22	2018-05-08	Ambrx Inc	human growth hormone formulations comprising an unnaturally encoded amino acid
SG158186A1 (en)	2004-12-22	2010-01-29	Ambrx Inc	Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
BRPI0518661A2 (en)	2004-12-22	2008-12-02	Ambrx Inc	Methods for expression and purification of recombinant human growth hormone
WO2006133089A2 (en)	2005-06-03	2006-12-14	Ambrx, Inc.	Improved human interferon molecules and their uses
MX2008002149A (en)	2005-08-18	2008-04-22	Ambrx Inc	COMPOSITIONS OF tRNA AND USES THEREOF.
CN101454461A (en)	2005-11-16	2009-06-10	Ambrx公司	Methods and compositions comprising unnatural amino acids
US9133495B2 (en)	2006-09-08	2015-09-15	Ambrx, Inc.	Hybrid suppressor tRNA for vertebrate cells
WO2008030614A2 (en)	2006-09-08	2008-03-13	Ambrx, Inc.	Suppressor trna transcription in vertebrate cells
EP2615108B1 (en)	2006-09-08	2016-10-26	Ambrx, Inc.	Modified human plasma polypeptide or fc scaffolds and thier uses
CN104163864B (en)	2007-03-30	2017-08-01	Ambrx公司	Through modifying the polypeptides of FGF 21 and its purposes
WO2008137471A2 (en)	2007-05-02	2008-11-13	Ambrx, Inc.	Modified interferon beta polypeptides and their uses
US8946148B2 (en)	2007-11-20	2015-02-03	Ambrx, Inc.	Modified insulin polypeptides and their uses
SG188143A1 (en)	2008-02-08	2013-03-28	Ambrx Inc	Modified leptin polypeptides and their uses
NZ600382A (en)	2008-07-23	2013-11-29	Ambrx Inc	Modified bovine G-CSF polypeptides and their uses
HUE035168T2 (en)	2008-09-26	2018-05-02	Ambrx Inc	Modified animal erythropoietin polypeptides and their uses
EA201170493A1 (en)	2008-09-26	2011-10-31	Амбркс, Инк.	MICROORGANISMS AND VACCINES DEPENDING ON REPLICATION OF NON-NATURAL AMINO ACIDS
EP2805965A1 (en)	2009-12-21	2014-11-26	Ambrx, Inc.	Modified porcine somatotropin polypeptides and their uses
CN102753573A (en)	2009-12-21	2012-10-24	Ambrx公司	Modified bovine somatotropin polypeptides and uses thereof
MX2010005637A (en) *	2010-05-21	2011-11-24	Univ Mexico Nacional Autonoma	Modified polyhedrin, and polyhedras and biotechnological products obtained from same.
US20130171129A1 (en)	2010-06-23	2013-07-04	Fasseli Joseph Coulibaly	Constrained immunogenic compositions and uses therefor
US9567386B2 (en)	2010-08-17	2017-02-14	Ambrx, Inc.	Therapeutic uses of modified relaxin polypeptides
SI3572091T1 (en)	2010-08-17	2024-07-31	Ambrx, Inc.,	Modified relaxin polypeptides and their uses
TWI480288B (en)	2010-09-23	2015-04-11	Lilly Co Eli	Formulations for bovine granulocyte colony stimulating factor and variants thereof
CN104812893B (en)	2012-11-22	2018-08-03	旭化成医疗株式会社	The production method of the parvovirus of high infection titer
SMT202100388T1 (en)	2014-10-24	2021-09-14	Bristol Myers Squibb Co	Modified fgf-21 polypeptides and uses thereof
CN106701826B (en) *	2015-11-13	2021-04-20	中国科学院武汉病毒研究所	A recombinant plasmid that can be used to package a large amount of exogenous proteins and its construction method and application
JP2018033404A (en) *	2016-09-01	2018-03-08	国立大学法人東京工業大学	Modified polyhedrin protein and use thereof
BR112019016139A2 (en)	2017-02-08	2020-04-07	Bristol-Myers Squibb Company	modified relaxin polypeptide comprising a pharmacokinetic enhancer and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0127839A2 (en) *	1983-05-27	1984-12-12	THE TEXAS A&M UNIVERSITY SYSTEM	Method for producing a recombinant baculovirus expression vector

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4745051A (en) *	1983-05-27	1988-05-17	The Texas A&M University System	Method for producing a recombinant baculovirus expression vector

1988
- 1988-03-02 AU AU17176/88A patent/AU1717688A/en not_active Abandoned
- 1988-03-02 EP EP19880904294 patent/EP0349594A4/en not_active Withdrawn
- 1988-03-02 WO PCT/US1988/000631 patent/WO1988007082A1/en not_active Ceased
- 1988-03-02 JP JP63504028A patent/JPH02502876A/en active Pending

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0127839A2 (en) *	1983-05-27	1984-12-12	THE TEXAS A&M UNIVERSITY SYSTEM	Method for producing a recombinant baculovirus expression vector

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
EMBO JOURNAL, vol. 5, no. 6, 1986, pages 1359-1365, IRL Press Ltd, Oxford, GB; K. KURODA et al.: "Expression of the influenza virus haemagglutinin in insect cells by a baculovirus vector" *
PROTEIN ENGINEERING, vol. 1, no. 4, August/September 1987, pages 359-366, IRL Press Ltd, Oxford, GB; V.C. EMERY et al.: "The development of multiple expression vectors for high level synthesis of eukaryotic proteins: expression of LCMV-N and AcNPV polyhedrin protein by a recombinant baculovirus" *
See also references of WO8807082A1 *

Also Published As

Publication number	Publication date
WO1988007082A1 (en)	1988-09-22
AU1717688A (en)	1988-10-10
JPH02502876A (en)	1990-09-13
EP0349594A1 (en)	1990-01-10

Publication	Publication Date	Title
EP0349594A4 (en)	1990-09-26	Recombinant baculovirus occlusion bodies in vaccines and biological insecticides
GB2201596B (en)	1991-01-09	N-cyanoisothioureas and use thereof in pest control
EP0351314A3 (en)	1990-03-21	Medical material and medical implement
PL271962A1 (en)	1989-06-12	Insecticide and/or acaricide
IL94478A0 (en)	1991-03-10	Tines structure in clinical applicator
IL90489A0 (en)	1990-01-18	Recombinant coccidiosis vaccines and their preparation
OA09736A (en)	1993-11-30	"Human interleukin-3 and muteins thereof".
IL102704A0 (en)	1993-01-14	Dna coding for human serum albumin and its use
EP0481600A3 (en)	1993-04-21	Materials useful in human and veterinary medicine
EP0340333A3 (en)	1990-08-29	Novel physiologically active polypeptide and pharmaceutical composition
IL90690A0 (en)	1990-01-18	Tissue equivalents and their preparation
EP0304802A3 (en)	1990-03-28	Pharmaceutical composition and the use thereof
AP9000161A0 (en)	1990-04-30	Insecticidal treatment and composition therefor
EP0433961A3 (en)	1992-12-09	Medical device with oligodynamic active material
EP0435199A3 (en)	1991-09-11	Acrylic gel material and acrylic gel preparation
IL81895A0 (en)	1987-10-20	N-pyridyloxyphenyl-isothioureas,their preparation and their use in pest control
ZA902401B (en)	1991-01-30	Phytosanitary preparation and use thereof
EG18920A (en)	1994-06-30	N - benzoyl - n'- 2,5 dihalo - 4 - perefluoroalko-xyphenylureas, their preparation and use in the control of pests
JPS6425796A (en)	1989-01-27	Insulin bonding peptide and its use
NZ227594A (en)	1991-09-25	Human interleukin-1alpha and preparations thereof
GB8920304D0 (en)	1989-10-25	Fr901375 substance and preparation thereof
EG18799A (en)	1994-02-28	Phenylthioureas, phenylisothioureas and phenylcarbodumides their preparation and use in the control of pests
GB8915023D0 (en)	1989-08-23	Improvements in or relating to medical syringes
GB8918370D0 (en)	1989-09-20	Material for use in biological cryoprotection
ZA871433B (en)	1987-10-28	Benzoylphenylureas,the preparation thereof and the use thereof in pest control

Legal Events

Date	Code	Title	Description
1989-11-25	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1990-01-10	17P	Request for examination filed	Effective date: 19890914
1990-01-10	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE
1990-09-26	A4	Supplementary search report drawn up and despatched	Effective date: 19900808
1990-09-26	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE
1991-02-26	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
1991-04-17	18D	Application deemed to be withdrawn	Effective date: 19901016